BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7776411)

  • 1. A worse prognosis for smokers with prostate cancer.
    Daniell HW
    J Urol; 1995 Jul; 154(1):153-7. PubMed ID: 7776411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A better prognosis for obese men with prostate cancer.
    Daniell HW
    J Urol; 1996 Jan; 155(1):220-5. PubMed ID: 7490839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of smoking on outcome following external radiation for localized prostate cancer.
    Pickles T; Liu M; Berthelet E; Kim-Sing C; Kwan W; Tyldesley S;
    J Urol; 2004 Apr; 171(4):1543-6. PubMed ID: 15017216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy.
    Pantarotto J; Malone S; Dahrouge S; Gallant V; Eapen L
    BJU Int; 2007 Mar; 99(3):564-9. PubMed ID: 17166241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and risk of total and fatal prostate cancer in United States health professionals.
    Giovannucci E; Rimm EB; Ascherio A; Colditz GA; Spiegelman D; Stampfer MJ; Willett WC
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):277-82. PubMed ID: 10207628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The independent impact of extended pattern biopsy on prostate cancer stage migration.
    Master VA; Chi T; Simko JP; Weinberg V; Carroll PR
    J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies on the prognostic factors in prostate cancer].
    Horii Y; Yoshida T; Hirai S; Yamauchi T
    Hinyokika Kiyo; 1998 Oct; 44(10):701-5. PubMed ID: 9850833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men.
    Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR
    Cancer; 2007 Mar; 109(6):1192-202. PubMed ID: 17311344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
    J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
    Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
    J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking history and cancer patient survival: a hospital cancer registry study.
    Yu GP; Ostroff JS; Zhang ZF; Tang J; Schantz SP
    Cancer Detect Prev; 1997; 21(6):497-509. PubMed ID: 9398990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and prognosis in women with breast cancer.
    Fentiman IS; Allen DS; Hamed H
    Int J Clin Pract; 2005 Sep; 59(9):1051-4. PubMed ID: 16115181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study.
    Houterman S; Janssen-Heijnen ML; Verheij CD; Kil PJ; van den Berg HA; Coebergh JW
    Prostate Cancer Prostatic Dis; 2006; 9(2):179-84. PubMed ID: 16534509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection.
    Egevad L; Granfors T; Karlberg L; Bergh A; Stattin P
    J Urol; 2002 Aug; 168(2):509-13. PubMed ID: 12131299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.
    Murta-Nascimento C; Romero AI; Sala M; Lorente JA; Bellmunt J; Rodero NJ; Lloreta J; Hospital À; Burón A; Castells X; Macià F
    Eur J Cancer Prev; 2015 Jul; 24(4):335-9. PubMed ID: 25075878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.